Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 556

1.

Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.

Lubman D, Koutsogiannis Z, Kronborg I.

Drug Alcohol Rev. 2003 Dec;22(4):433-6.

PMID:
14660133
2.

Unintentional rapid opioid detoxification: case report.

Singh SM, Sharma B.

Psychiatr Danub. 2009 Mar;21(1):65-7. Review.

3.

Measurement of symptom withdrawal severity in a 24-hour period after the anesthesia-assisted rapid opiate detoxification procedure.

Teplin D, Raz B, Daiter J, Varenbut M, Zachos CT, Whang P, Herman S, Chaudry S, Yung M.

Am J Drug Alcohol Abuse. 2005;31(2):327-35.

PMID:
15912719
4.
5.

Acute opioid withdrawal in the emergency department: inadvertent naltrexone abuse?

Bristow K, Meek R, Clark N.

Emerg Med (Fremantle). 2001 Sep;13(3):359-63.

PMID:
11554869
6.

Naltrexone shortened opioid detoxification with buprenorphine.

Umbricht A, Montoya ID, Hoover DR, Demuth KL, Chiang CT, Preston KL.

Drug Alcohol Depend. 1999 Oct 1;56(3):181-90.

PMID:
10529020
7.

Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.

Bochud Tornay C, Favrat B, Monnat M, Daeppen JB, Schnyder C, Bertschy G, Besson J.

Drug Alcohol Depend. 2003 Apr 1;69(3):283-8.

PMID:
12633914
8.

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers.

Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP.

Psychopharmacology (Berl). 1999 Jan;141(1):37-46.

PMID:
9952063
9.

Low efficacy of non-opioid drugs in opioid withdrawal symptoms.

Hermann D, Klages E, Welzel H, Mann K, Croissant B.

Addict Biol. 2005 Jun;10(2):165-9.

PMID:
16191669
10.

Naltrexone-assisted rapid methadone discontinuation: a pilot study.

Camarasa X, Khazaal Y, Besson J, Zullino DF.

Eur Addict Res. 2007;13(1):20-4.

PMID:
17172775
12.

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.

Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.

Arch Gen Psychiatry. 2005 Oct;62(10):1157-64.

PMID:
16203961
13.

Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.

Naderi-Heiden A, Naderi A, Naderi MM, Rahmani-Didar F, Salimi AR, Gleiss A, Kasper S, Frey R.

Pharmacopsychiatry. 2010 Jun;43(4):130-7. doi: 10.1055/s-0029-1242820. Epub 2010 Jan 25.

PMID:
20101570
14.

Combating opiate dependence: a comparison among the available pharmacological options.

Gonzalez G, Oliveto A, Kosten TR.

Expert Opin Pharmacother. 2004 Apr;5(4):713-25. Review.

PMID:
15102558
15.

Emergency department presentations of naltrexone-accelerated detoxification.

Armstrong J, Little M, Murray L.

Acad Emerg Med. 2003 Aug;10(8):860-6.

16.

[A clinical-experimental study of narcotic properties of opiate receptor agonists-antagonists and experience in their use in drug addiction practice].

Sofronov AG, Kuz'min AV, Pchelintsev MV, Belogurov SB.

Anesteziol Reanimatol. 1994 Jul-Aug;(4):13-5. Russian.

PMID:
7802310
17.

Opiate addiction in China: current situation and treatments.

Tang YL, Zhao D, Zhao C, Cubells JF.

Addiction. 2006 May;101(5):657-65. Review.

PMID:
16669899
18.

Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.

Wallen MC, Lorman WJ, Gosciniak JL.

J Addict Dis. 2006;25(1):23-31.

PMID:
16597570
19.

Use of very low-dose naltrexone during opiate detoxification.

Mannelli P, Gottheil E, Buonanno A, De Risio S.

J Addict Dis. 2003;22(2):63-70.

PMID:
12703669
20.

Naltrexone and buprenorphine combination in the treatment of opioid dependence.

Gerra G, Fantoma A, Zaimovic A.

J Psychopharmacol. 2006 Nov;20(6):806-14. Epub 2006 Jan 9.

PMID:
16401652

Supplemental Content

Support Center